Pharma S&M Offshoring: The Next Level
||Save. Impact. Innovate
It is an open secret that the Global Pharmaceutical Industry's Sales and Marketing model is under tremendous pressure. The spate of layoffs, re-organizations and growth in outsourcing announcements across companies are a testament to the fact that the pharmaceutical industry is trying to reconfigure itself and adapt to a new reality.
Over the next few years most of the large and mid-size pharmaceutical companies will aggressively use offshore delivery capacity as a significant element of their commercial support organizations and successfully target significant dollar savings.
In this paper, Manish Gupta, Director, Indegene, and Rajesh Nair, President, Indegene, explore how pharmaceutical companies can impact their much larger brand budgets and drive efficiency in Promotional Medical Education, eMarketing, Medical Affairs, Sales Training, Medical Communication and Publication Planning activities through offshoring initiatives.
This whitepaper will help you understand
1) The fundamental approaches to offshoring Marketing and Promotional activities
2) The Hybrid Delivery Model-By harmoniously balancing the onshore and offshore components, substantial cost benefits, operational scalability and effective programs can be guaranteed.
3) Unbundling, an emerging strategy for utilizing the best of both worlds - your incumbent agency of record, and the offshore-driven vendor
Provided by: Indegene
Register or Login below to download this and other white papers.
If you would like to post your white paper on PharmaLive, please contact us.